{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:28:38Z","timestamp":1791822518311,"version":"4.3.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Soluble growth stimulation expressed gene 2 (sST2) is the receptor of interleukin (IL)-33. We hypothesized the IL-33\/ST2 pathway may be closely related to the progression of coronary atherosclerotic lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed 262 patients, including 63 with stable angina pectoris (SAP), 97 with acute coronary syndrome (ACS), and 102 control subjects. Plasma sST2 levels were determined using ELISA. Gensini scores were calculated. Patients with ACS and SAP were further divided according to the complexity of atherosclerotic lesions (simple\/complex). Statistical analysis was performed on all data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The plasma sST2 levels were significantly higher in patients with coronary artery disease (CAD) than in the control group, and were significantly higher in ACS patients with complex lesions than in those with simple lesions. There were no correlations between plasma sST2 level and both the number of culprit vessels and Gensini score. Multivariate stepwise regression analysis revealed that angiographically detected complex lesions were independently correlated with plasma sST2 level. Logistic regression analyses showed that sST2 was an independent factor of both CAD and the lesion type (simple\/complex) of ACS. For the diagnosis of ACS and complex lesions, the area under the receiver operating characteristic curve of sST2 was 0.651.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The plasma sST2 level was not correlated with the stenosis severity of coronary atherosclerosis. A relationship between the plasma sST2 level and the morphology of complex lesions was found for the first time, especially in ACS patients. It may be a new marker for assessing the stability and complexity of atherosclerotic plaques.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000851","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T15:12:40Z","timestamp":1581347560000},"page":"628-635","source":"Crossref","is-referenced-by-count":15,"title":["Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis"],"prefix":"10.1097","volume":"31","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[{"name":"Emergency"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixu","family":"Fan","sequence":"additional","affiliation":[{"name":"Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[{"name":"Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Ma","sequence":"additional","affiliation":[{"name":"Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"R1-20230924","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"R2-20230924","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the International ST2 Consensus Panel.","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"key":"R3-20230924","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jchf.2016.09.010","article-title":"Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis.","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail"},{"key":"R4-20230924","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure.","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail"},{"key":"R5-20230924","doi-asserted-by":"crossref","first-page":"1112.e9","DOI":"10.1016\/j.amjmed.2017.02.034","article-title":"Prognostic value of soluble ST2 after myocardial infarction: a community oerspective.","volume":"130","author":"Jenkins","year":"2017","journal-title":"American J Med"},{"key":"R6-20230924","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease.","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R7-20230924","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cytogfr.2015.07.017","article-title":"The IL-33\/ST2 axis: role in health and disease.","volume":"26","author":"De la Fuente","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"R8-20230924","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.atherosclerosis.2014.12.048","article-title":"Histone deacetylases and atherosclerosis.","volume":"240","author":"Zheng","year":"2015","journal-title":"Atherosclerosis"},{"key":"R9-20230924","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice.","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R10-20230924","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease.","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"R11-20230924","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis.","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"R12-20230924","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis.","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"R13-20230924","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI200420479","article-title":"IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.","volume":"114","author":"Binder","year":"2004","journal-title":"J Clin Invest"},{"key":"R14-20230924","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.1000520","article-title":"IL-33 reduces macrophage foam cell formation.","volume":"185","author":"McLaren","year":"2010","journal-title":"J Immunol"},{"key":"R15-20230924","doi-asserted-by":"crossref","first-page":"e0161507","DOI":"10.1371\/journal.pone.0161507","article-title":"IL-33 receptor-expressing regulatory T cells are highly activated, th2 biased and suppress CD4 T cell proliferation through IL-10 and TGF\u03b2 release.","volume":"11","author":"Siede","year":"2016","journal-title":"PLoS One"},{"key":"R16-20230924","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imr.12218","article-title":"Macrophage phenotypes in atherosclerosis.","volume":"262","author":"Colin","year":"2014","journal-title":"Immunol Rev"},{"key":"R17-20230924","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1253\/circj.CJ-14-0621","article-title":"Macrophage phenotypes and their modulation in atherosclerosis.","volume":"78","author":"De Paoli","year":"2014","journal-title":"Circ J"},{"key":"R18-20230924","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/emmm.201201374","article-title":"Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype.","volume":"4","author":"Cardilo-Reis","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"7 Suppl","key":"R19-20230924","doi-asserted-by":"crossref","first-page":"48b","DOI":"10.1016\/j.amjcard.2015.01.041","article-title":"ST2 in stable and unstable ischemic heart diseases.","volume":"115","author":"Richards","year":"2015","journal-title":"Am J Cardiol"},{"key":"R20-20230924","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3349\/ymj.2016.57.6.1347","article-title":"Lack of superiority for soluble ST2 over high sensitive C-reactive protein in predicting high risk coronary artery calcium score in a community cohort.","volume":"57","author":"Oh","year":"2016","journal-title":"Yonsei Med J"},{"key":"R21-20230924","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1373\/clinchem.2013.209858","article-title":"Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.","volume":"60","author":"Dieplinger","year":"2014","journal-title":"Clin Chem"},{"key":"R22-20230924","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","article-title":"2011 ACCF\/AHA focused update of the Guidelines for the Management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R23-20230924","first-page":"485","article-title":"ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"61","author":"O\u2032Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R24-20230924","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fcvm.2017.00057","article-title":"Genome-wide association analysis for severity of coronary artery disease using the Gensini Scoring System.","volume":"4","author":"Zeller","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"R25-20230924","first-page":"529","article-title":"Subcommittee on Percutaneous Transluminal Coronary Angioplasty. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology\/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).","volume":"12","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"R26-20230924","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.ijcard.2012.05.073","article-title":"Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?","volume":"167","author":"Dhillon","year":"2013","journal-title":"Int J Cardiol"},{"key":"R27-20230924","doi-asserted-by":"crossref","first-page":"e95055","DOI":"10.1371\/journal.pone.0095055","article-title":"Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome.","volume":"9","author":"Demyanets","year":"2014","journal-title":"PLoS One"},{"key":"R28-20230924","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjcard.2010.09.011","article-title":"Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.","volume":"107","author":"Manzano-Fern\u00e1ndez","year":"2011","journal-title":"Am J Cardiol"},{"key":"R29-20230924","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.","volume":"4","author":"Ky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"R30-20230924","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2017.11.054","article-title":"Effect of plaque burden and morphology on myocardial blood flow and fractional flow reserve.","volume":"71","author":"Driessen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R31-20230924","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2018.10.066","article-title":"Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study.","volume":"73","author":"Williams","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R32-20230924","doi-asserted-by":"crossref","first-page":"e0156315","DOI":"10.1371\/journal.pone.0156315","article-title":"ST2L transmembrane receptor expression: an immunochemical study on endarterectomy samples.","volume":"11","author":"Marzullo","year":"2016","journal-title":"PLoS One"},{"key":"R33-20230924","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/hr.2016.16","article-title":"Elevated circulating sST2 associated with subclinical atherosclerosis in newly diagnosed primary hypertension.","volume":"39","author":"Ates","year":"2016","journal-title":"Hypertens Res"},{"key":"R34-20230924","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0002-9149(03)00457-0","article-title":"Plaque disruption and thrombus in Ambrose\u2019s angiographic coronary lesion types.","volume":"92","author":"Waxman","year":"2003","journal-title":"Am J Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:04:21Z","timestamp":1695539061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000851","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,7]]}}}